← Open Payments lookup

LILA PECKHAM-WICHMAN: Open Payments

NPI 1366409427 · LENEXA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$370 in 19 payments from 8 companies in 2025. Trend: 2023 $91 · 2024 $360 · 2025 $370

Food & beverage: $370
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc3$65
Teva Pharmaceuticals USA, Inc.3$60
Alkermes, Inc.3$59
ABBVIE INC.3$57
Otsuka America Pharmaceutical, Inc.3$57
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
Takeda Pharmaceuticals U.S.A., Inc.1$19
Vanda Pharmaceuticals Inc.1$14

Products named: INVEGA SUSTENNA, ARISTADA, VRAYLAR, REXULTI, UZEDY, CAPLYTA, TRINTELLIX, AUSTEDO XR.

Industry payments across KS — which companies pay providers there.